Group 1: Fund News - The recent liquidation of the Guolian Smart Dividend Stock Fund was announced, with a total fund share of only 6.8446 million [1] - Several QDII funds have imposed purchase limits, including Dachen Global Dollar Bond Fund and Wanjia Nasdaq 100 Index Fund, with a cap of 500,000 yuan for single accounts [2] - The performance gap among pharmaceutical funds has exceeded 120% year-to-date, with funds focused on Hong Kong innovative drugs leading the pack [3] Group 2: Fund Manager Insights - Fund manager Zou Hui from Industrial Bank maintains a long-term bullish outlook, citing macro policy support and structural highlights from new and old economic drivers [3] - Key investment areas for the second half of the year include technology innovation, dividend expansion, and potential bottom reversals in sectors like military, agriculture, and certain new energy areas [3] Group 3: ETF Market Review - The Shanghai Composite Index rose by 0.17%, while the Shenzhen Component Index and ChiNext Index fell by 0.77% and 1.62%, respectively, with total trading volume reaching 1.84 trillion yuan [4] - Oil and gas stocks showed strong performance, with the Oil and Gas Resource ETF leading with a gain of 3.35% [4][5] Group 4: ETF Opportunities - The government continues to emphasize anti-involution and stable growth, with the chemical industry undergoing capacity elimination assessments, which may enhance competitiveness [7]